Insulin-like growth factor-binding protein-2 is a target for the immunomodulation of breast cancer.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000595:Amino Acid Sequence; D000818:Animals; D001943:Breast Neoplasms / Q000276:immunology / Q000628:therapy*; D045744:Cell Line, Tumor; D005260:Female; D000949:Histocompatibility Antigens Class II / Q000276:immunology; D006801:Humans; D018971:Insulin-Like Growth Factor Binding Protein 2 / Q000276:immunology*; D007371:Interferon-gamma / Q000096:biosynthesis; D051379:Mice; D008822:Mice, Transgenic; D008875:Middle Aged; D008969:Molecular Sequence Data; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D014611:Vaccination
D000949:Histocompatibility Antigens Class II; D018971:Insulin-Like Growth Factor Binding Protein 2; D007371:Interferon-gamma